Neurophysiological markers of relapse, remission and long-term recovery processes in MS.
Jones
S J
SJ
Department of Clinical Neurophysiology, National Hospital for Neurology and Neurosurgery, London, UK. S.J.Jones@ion.ucl.ac.uk
Brusa
A
A
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D015415:Biomarkers; D003430:Cross-Sectional Studies; D005074:Evoked Potentials, Visual / Q000187:drug effects / Q000502:physiology; D005500:Follow-Up Studies; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D009900:Optic Nerve / Q000503:physiopathology; D009902:Optic Neuritis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D008775:Methylprednisolone